Researchers from Weill Cornell Medical College and elsewhere present findings from a prostate cancer analysis performed with a computational tool called RegNetDriver, designed to uncover cancer driver mutations based on integrated genomic and epigenomic data. For its proof-of-principle analyses, the team used RegNetDriver to analyze structural variant, transcription factor, variant, promoter, enhancer, and other data gleaned from 521 prostate cancer tumors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.